We are live on ! Find out more
STIM icon

Neuronetics

105 hedge funds and large institutions have $351M invested in Neuronetics in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

26,200% more call options, than puts

Call options by funds: $1.05M | Put options by funds: $4K

200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 11

46% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 24

37% more capital invested

Capital invested by funds: $256M → $351M (+$94.3M)

27% more funds holding

Funds holding: 83105 (+22)

8.96% more ownership

Funds ownership: 81.61%90.57% (+9%)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
105
Holders Change
+22
Holders Change %
+26.51%
% of All Funds
1.83%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
33
Increased
35
Reduced
24
Closed
11
Calls
$1.05M
Puts
$4K
Net Calls
+$1.05M
Net Calls Change
+$286K
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
DAFNA Capital Management
California
$4.07M
Northern Trust
27
Northern Trust
Illinois
$3.81M +$2.71M +196,380 +472%
Invesco
28
Invesco
Georgia
$3.69M +$3.18M +230,383 New
FWC
29
First Washington Corp
Washington
$3.58M
Norges Bank
30
Norges Bank
Norway
$3.47M +$2.99M +216,600 New
Russell Investments Group
31
Russell Investments Group
United Kingdom
$3.3M -$1.46M -105,352 -34%
MAG
32
Millrace Asset Group
Pennsylvania
$3.08M +$708K +51,228 +36%
Two Sigma Investments
33
Two Sigma Investments
New York
$3.08M -$860K -62,214 -24%
EIM
34
Essex Investment Management
Massachusetts
$3.05M +$384K +27,801 +17%
ACM
35
Altium Capital Management
New York
$2.96M +$650K +47,054 +34%
William Blair & Company
36
William Blair & Company
Illinois
$2.49M +$72.4K +5,242 +3%
GF
37
Gabelli Funds
New York
$2.31M +$82.9K +5,999 +4%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$2.16M +$89.8K +6,500 +5%
PCM
39
Prelude Capital Management
New York
$2.13M +$1.84M +133,203 New
Goldman Sachs
40
Goldman Sachs
New York
$1.87M +$367K +26,594 +30%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.72M +$576K +41,664 +63%
N
42
Nuveen
North Carolina
$1.41M +$1.22M +87,949 New
Ameriprise
43
Ameriprise
Minnesota
$1.27M -$60.8K -4,400 -5%
Deutsche Bank
44
Deutsche Bank
Germany
$1.26M +$112K +8,109 +11%
OAM
45
Oberweis Asset Management
Illinois
$1.26M
HighTower Advisors
46
HighTower Advisors
Illinois
$1.19M
Millennium Management
47
Millennium Management
New York
$1.02M -$3.47M -251,437 -80%
Charles Schwab
48
Charles Schwab
California
$991K +$854K +61,831 New
Renaissance Technologies
49
Renaissance Technologies
New York
$906K -$4.33M -313,500 -85%
Morgan Stanley
50
Morgan Stanley
New York
$883K -$3.22M -233,295 -81%

STIM Hedge Fund Activity: Q2 2021 in Review

105 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2021, worth a combined $351M — up 37% from $256M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new STIM positions and 11 closed out — a net gain of 22 holders — while 35 added to existing stakes and 24 trimmed.

The largest buyer was Cannell Capital, adding an estimated $17.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.

  • 105 institutional investors held Neuronetics (STIM) as of Q2 2021, up from 83 in Q1 2021.
  • Funds reported $351M of Neuronetics stock for Q2 2021, up 37% quarter-over-quarter.
  • 33 funds opened new Neuronetics positions in Q2 2021 and 11 closed out, a net change of +22 holders.
  • The largest Neuronetics buyer in Q2 2021 was Cannell Capital, an estimated $17.2M added.
  • The largest Neuronetics seller in Q2 2021 was Deerfield Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q2 2021.